I rarely speculate, just guesses.
If there is a major announcement of a solid deal with a large US player, with a major existing market share in the US healthcare/medical/pain space - .004 to .01 cents, settles, who knows where....
If any wisdom whatsoever prevails on fixing the stupid BoD makeup and # of Directors AND the absurd share structure .008 to 1.5 cents, with higher probability of sustainability.
Make the toxic Whelan name disappear? Add 1.5 cents, sustainability and stays out of the toilet.